Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C4orf46 pseudogene 2 is a non-coding genetic sequence homologous to the functional gene chromosome 4 open reading frame 46 (C4orf46), whose protein product is of unknown function but is expressed in a variety of tissues. C4orf46 has several related pseudogenes located on chromosomes 6, 8, 16, and X. A pseudogene does not encode a functional protein; instead, it is a genetic relic arising from duplication or mutation events, characterized by disabling mutations or a lack of coding potential. There is no recognized role for C4orf46 pseudogene 2 in biology, disease, or therapeutics. The parent gene, C4orf46 (also named RCDG1), may play a role in renal cell carcinoma differentiation, but the pseudogene itself is not studied as a drug target or biomarker. This entry is not a standard therapeutic target, and its inclusion likely derives from confusion with C4orf46 or overextension of naming conventions for pseudogenes. Use caution when interpreting literature to avoid conflating pseudogene function with parent gene data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 4 open reading frame 46 pseudogene 2 (C4orf46P2).